Scandinavian Pharma Group ApS — Credit Rating and Financial Key Figures
CVR number: 42650668
Islands Brygge 108, 2300 København S
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | -12.03 | - 307.71 |
| Employee benefit expenses | -8.29 | |
| EBIT | -12.03 | - 316.00 |
| Other financial expenses | -0.05 | -1.67 |
| Pre-tax profit | -12.08 | - 317.66 |
| Income taxes | 71.03 | |
| Net earnings | -12.08 | - 246.64 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Raw materials and consumables | 66.93 | 71.84 |
| Inventories total | 66.93 | 71.84 |
| Current trade debtors | 56.33 | 23.79 |
| Current deferred tax assets | 80.96 | |
| Short term receivables total | 56.33 | 104.75 |
| Cash and bank deposits | 28.16 | 64.81 |
| Cash and cash equivalents | 28.16 | 64.81 |
| Balance sheet total (assets) | 151.42 | 241.40 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Retained earnings | -12.08 | |
| Profit of the financial year | -12.08 | - 246.64 |
| Shareholders equity total | 27.92 | - 218.72 |
| Non-current liabilities total | ||
| Current owed to participating | 114.78 | 460.12 |
| Short-term deferred tax liabilities | 8.72 | |
| Current liabilities total | 123.50 | 460.12 |
| Balance sheet total (liabilities) | 151.42 | 241.40 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.